China Nominates Health Official to Lead WHO Amid Global Health Leadership Shift
China has nominated Dr. Song Li to lead the WHO, signaling its growing influence in global health governance.
4 min read
China has officially nominated Dr. Song Li, a senior health official from the Chinese Communist Party, to lead the World Health Organization (WHO) in a move that underscores its increasing influence in global health governance. The nomination was confirmed by Chinese Foreign Ministry spokeswoman Mao Ning at a press conference, marking the latest development in a geopolitical struggle over leadership of the United Nations health agency.
China’s Bid for Influence
The nomination comes amid a broader effort by China to assert its role in international organizations, particularly following the United States’ withdrawal from the WHO in 2020 under President Donald Trump. Trump criticized the agency for being too heavily influenced by China, despite the U.S. paying significantly more in annual contributions than China. At the time, Trump claimed that China had ‘total control’ over the WHO, despite its relatively smaller financial commitment of $40 million annually compared to the U.S.’s $450 million.
Although the Biden administration reversed Trump’s decision to withdraw from the WHO in 2021, Trump reasserted his stance by signing an executive order to pull out again in January 2025. The U.S. remains the largest single contributor to the WHO, but its voting rights were suspended in May due to unpaid dues. The World Health Assembly has stated it will not officially recognize the U.S. withdrawal until all outstanding payments are made.
Dr. Song Li’s Background
Dr. Song Li, the former director of the Department of Women and Child Health at China’s National Health Commission, is the first mainland Chinese candidate to be nominated for the WHO director-general position. She also holds a position on the secretariat of the All-China Women’s Federation, an organ of the Chinese Communist Party directly supervised by Party leadership.
Song’s career includes a six-month visit as a ‘visiting scholar in global health’ at Harvard University in 2010. She was involved in the early response to the Wuhan coronavirus pandemic, helping to establish procedures for maternity and newborn care and creating networks for treating pregnant women infected with the virus. Her work has positioned her as a key figure in China’s public health strategy.
Global Candidates and WHO’s Future
Song is the seventh candidate to be nominated for the WHO director-general role, joining others from Belgium, Saudi Arabia, Qatar, Indonesia, Spain, and Botswana. The current director-general, Dr. Tedros Adhanom Ghebreyesus, is set to leave office in August 2027 after a five-year term. The next director-general will be elected by the World Health Assembly, which includes representatives from all member states.
The WHO has faced significant challenges, including a 21 percent reduction in its base budget following the U.S. withdrawal under Trump. The organization has also been dealing with the fallout from the global pandemic, which has tested its capacity to coordinate international health responses. The new director-general will play a critical role in shaping the agency’s future strategy and ensuring its continued relevance in a rapidly changing global health landscape.
China’s Strategic Move
According to a former senior WHO official quoted by Reuters, China may be using Song’s candidacy as leverage to gain greater influence within the agency. The official suggested that ensuring the presence of more Chinese senior officials at the WHO could help China shape the organization’s policies and priorities. This aligns with China’s broader goal of increasing its soft power and influence in global governance.
Mao Ning emphasized that China’s nomination of Dr. Song Li reflects its commitment to multilateralism and its support for the WHO. She stated that if elected, Song would help the organization play a more active role in improving global health and wellbeing. This statement comes as the WHO continues to navigate complex geopolitical dynamics and the ongoing challenges of global health security.
Context and Implications
The nomination of Dr. Song Li is part of a larger trend of China’s increasing involvement in international organizations. The country has been actively seeking to expand its influence in the United Nations and other multilateral bodies, particularly in the wake of the U.S. withdrawal from several key institutions. This move is also seen as a response to the growing importance of global health cooperation in the face of pandemics and other transnational challenges.
While the WHO has traditionally been a platform for consensus-building, the nomination of a Chinese official signals a shift in the balance of power within the organization. The agency’s ability to maintain its role as a neutral and effective global health body will depend on its capacity to manage these geopolitical tensions and ensure that its focus remains on public health outcomes.
Conclusion
The nomination of Dr. Song Li to lead the WHO represents a significant development in the global health governance landscape. As the agency prepares for its next leadership transition, the role of the new director-general will be crucial in shaping the future of international health cooperation. The coming months will be critical for the WHO as it works to navigate the complex interplay of politics, public health, and global cooperation in an increasingly interconnected world.
Source: Breitbart
